Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial

NCT06494878 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT06494878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06494878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial
Lead sponsor
University of Calgary
Phase
Phase 3
Overall status
Recruiting
Start date
June 4, 2026
Completion date
December 31, 2030
Enrollment
8,805 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, low molecular weight heparin, postpartum period, venous thromboembolism